蛋白质测定市场 - 全球产业规模、份额、趋势、机会和预测，按类型、按产品、按技术、按应用、按最终用户、按地区和竞争进行细分，2020 年至 2030 年

2024 年全球蛋白质测定市场规模为 27.2 亿美元，预计到 2030 年将达到 39.6 亿美元，预测期内复合年增长率为 6.40%。受药物开发、临床诊断、生物技术和生物製药生产等领域对精确蛋白质定量需求不断增长的推动，该市场正在稳步扩张。蛋白质测定可以测量蛋白质的浓度、结构或功能，对于疾病理解、治疗进展和法规遵循至关重要。测定技术的进步、全球疾病负担的增加以及科研和医疗保健领域对蛋白质分析的迫切需求推动了该市场的发展。专注于测定创新、客製化解决方案和协作策略的公司在这一不断变化的市场格局中占据有利地位，能够获得竞争优势。

关键市场驱动因素

慢性病发生率上升和人口老化

主要市场挑战

先进检测技术和仪器成本高昂

主要市场趋势

高通量和自动化蛋白质测定技术的采用日益增多

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：蛋白质测定市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按类型（染料结合测定、基于试纸的测定、基于铜离子的测定、其他）
  • 依产品（试剂、试剂盒、仪器及配件）
  • 依技术（比色蛋白质测定、基于萤光的蛋白质测定、基于吸光度的蛋白质测定）
  • 按应用（药物研发、疾病诊断、其他）
  • 按最终用户（製药和生物技术公司、临床实验室、医院、学术研究机构等）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第六章：北美蛋白质测定市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲蛋白质测定市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙

第八章：亚太蛋白质测定市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美洲蛋白质测定市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东和非洲蛋白质测定市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 最新动态
• 产品发布
• 併购

第 13 章：全球蛋白质测定市场：SWOT 分析

第 14 章：竞争格局

• Becton Dickinson and Co
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories Inc
• Merck KGaA
• Abcam PLC
• PerkinElmer Inc.
• QIAGEN NV
• Lonza Group AG
• Bio-Techne Corp
• Illumina Inc

第 15 章：策略建议

第16章调查会社について・免责事项

The Global Protein Assays Market was valued at USD 2.72 Billion in 2024 and is anticipated to reach USD 3.96 Billion by 2030, growing at a CAGR of 6.40% during the forecast period. The market is expanding steadily, driven by increasing demand for accurate protein quantification across applications in drug development, clinical diagnostics, biotechnology, and biopharmaceutical production. Protein assays, which measure protein concentration, structure, or function, are crucial for disease understanding, therapeutic advancement, and regulatory compliance. The market is bolstered by advancements in assay technology, a rising global disease burden, and the critical need for protein analysis in both research and healthcare. Companies that focus on assay innovation, tailored solutions, and collaborative strategies are well-positioned to gain competitive advantage in this evolving landscape.

Key Market Drivers

Rising Incidence of Chronic Diseases and Aging Population

The increasing prevalence of chronic diseases and the expanding elderly population are significant contributors to the growth of the Global Protein Assays Market. According to WHO data, non-communicable diseases accounted for roughly 75% of non-pandemic deaths worldwide in 2021. The demand for reliable protein measurement tools continues to grow as healthcare systems and life sciences organizations prioritize early detection, treatment monitoring, and long-term disease management. For instance, global cancer cases are projected to hit 35 million by 2050-up 77% from 2022. Cardiovascular diseases caused 17.9 million deaths in 2019, with over 75% in low- and middle-income nations. Additionally, WHO reported that 14% of adults had diabetes in 2022, doubling from 1990 levels. Protein assays are essential in quantifying biomarkers like CRP, troponins, and cancer antigens for disease diagnosis and treatment monitoring. Regular testing for chronic conditions also fuels recurring demand for assay kits and reagents, as preventive healthcare models increasingly incorporate protein analysis for early disease detection.

Key Market Challenges

High Cost of Advanced Assay Technologies and Instruments

A significant challenge in the Protein Assays Market is the high cost associated with acquiring and maintaining sophisticated assay platforms. Advanced technologies such as mass spectrometry or automated microfluidic systems entail high capital expenditure and ongoing operational costs. Expenses related to specialized reagents, calibration, skilled personnel, and frequent quality control further raise the total cost of ownership. These high costs are especially prohibitive for smaller labs and institutions in emerging markets, where budget constraints limit access to cutting-edge tools. This results in a technology access gap between well-funded facilities and resource-constrained organizations, slowing the widespread adoption of advanced protein assay technologies.

Key Market Trends

Rising Adoption of High-Throughput and Automated Protein Assay Technologies

The demand for high-throughput and automated protein quantification is rising across pharmaceutical, biotech, and academic research sectors. As research complexity grows, laboratories require scalable solutions to enhance speed, accuracy, and productivity. Automated systems allow parallel processing of large sample volumes, reduce manual errors, and support continuous operations. These technologies are particularly useful in early-stage drug discovery and clinical research, where reproducibility and efficiency are critical. Integration with liquid handling robots and microplate readers is becoming common, and vendors offering automation-compatible reagents and instruments are increasingly favored. This trend is also encouraging collaborations between assay manufacturers and automation technology providers to meet evolving user demands.

Key Market Players

• Becton Dickinson and Co
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories Inc
• Merck KGaA
• Abcam PLC
• PerkinElmer Inc.
• QIAGEN NV
• Lonza Group AG
• Bio-Techne Corp
• Illumina Inc

Report Scope:

In this report, the Global Protein Assays Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Protein Assays Market, By Type:

• Dye Binding Assays
• Test Strip-Based Assays
• Copper-Ion-Based Assays
• Others

Protein Assays Market, By Product:

• Reagents
• Kits
• Instruments and Accessories

Protein Assays Market, By Technology:

• Colorimetric Protein Assays
• Fluorescence-Based Protein Assays
• Absorbance-Based Protein Assays

Protein Assays Market, By Application:

• Drug Discovery and Development
• Disease Diagnosis
• Others

Protein Assays Market, By End User:

• Pharmaceutical and Biotechnology Companies
• Clinical Laboratories
• Hospitals
• Academic Research Institutes
• Others

Protein Assays Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Protein Assays Market.

Available Customizations:

Global Protein Assays Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Protein Assays Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Dye Binding Assays, Test Strip-Based Assays, Copper-Ion-Based Assays, Others)
  • 5.2.2. By Product (Reagents, Kits, Instruments and Accessories)
  • 5.2.3. By Technology (Colorimetric Protein Assays, Fluorescence-Based Protein Assays, Absorbance-Based Protein Assays)
  • 5.2.4. By Application (Drug Discovery and Development, Disease Diagnosis, Others)
  • 5.2.5. By End User (Pharmaceutical and Biotechnology Companies, Clinical Laboratories, Hospitals, Academic Research Institutes, Others)
  • 5.2.6. By Region
  • 5.2.7. By Company (2024)
• 5.3. Market Map

6. North America Protein Assays Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Product
  • 6.2.3. By Technology
  • 6.2.4. By Application
  • 6.2.5. By End User
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Protein Assays Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Technology
      • 6.3.1.2.4. By Application
      • 6.3.1.2.5. By End User
  • 6.3.2. Canada Protein Assays Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Technology
      • 6.3.2.2.4. By Application
      • 6.3.2.2.5. By End User
  • 6.3.3. Mexico Protein Assays Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Technology
      • 6.3.3.2.4. By Application
      • 6.3.3.2.5. By End User

7. Europe Protein Assays Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Product
  • 7.2.3. By Technology
  • 7.2.4. By Application
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Protein Assays Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Technology
      • 7.3.1.2.4. By Application
      • 7.3.1.2.5. By End User
  • 7.3.2. United Kingdom Protein Assays Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Technology
      • 7.3.2.2.4. By Application
      • 7.3.2.2.5. By End User
  • 7.3.3. Italy Protein Assays Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Technology
      • 7.3.3.2.4. By Application
      • 7.3.3.2.5. By End User
  • 7.3.4. France Protein Assays Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Technology
      • 7.3.4.2.4. By Application
      • 7.3.4.2.5. By End User
  • 7.3.5. Spain Protein Assays Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Technology
      • 7.3.5.2.4. By Application
      • 7.3.5.2.5. By End User

8. Asia-Pacific Protein Assays Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Product
  • 8.2.3. By Technology
  • 8.2.4. By Application
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Protein Assays Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Technology
      • 8.3.1.2.4. By Application
      • 8.3.1.2.5. By End User
  • 8.3.2. India Protein Assays Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Technology
      • 8.3.2.2.4. By Application
      • 8.3.2.2.5. By End User
  • 8.3.3. Japan Protein Assays Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Technology
      • 8.3.3.2.4. By Application
      • 8.3.3.2.5. By End User
  • 8.3.4. South Korea Protein Assays Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Technology
      • 8.3.4.2.4. By Application
      • 8.3.4.2.5. By End User
  • 8.3.5. Australia Protein Assays Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Technology
      • 8.3.5.2.4. By Application
      • 8.3.5.2.5. By End User

9. South America Protein Assays Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Product
  • 9.2.3. By Technology
  • 9.2.4. By Application
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Protein Assays Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Technology
      • 9.3.1.2.4. By Application
      • 9.3.1.2.5. By End User
  • 9.3.2. Argentina Protein Assays Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Technology
      • 9.3.2.2.4. By Application
      • 9.3.2.2.5. By End User
  • 9.3.3. Colombia Protein Assays Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Technology
      • 9.3.3.2.4. By Application
      • 9.3.3.2.5. By End User

10. Middle East and Africa Protein Assays Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Product
  • 10.2.3. By Technology
  • 10.2.4. By Application
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Protein Assays Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Technology
      • 10.3.1.2.4. By Application
      • 10.3.1.2.5. By End User
  • 10.3.2. Saudi Arabia Protein Assays Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Technology
      • 10.3.2.2.4. By Application
      • 10.3.2.2.5. By End User
  • 10.3.3. UAE Protein Assays Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Technology
      • 10.3.3.2.4. By Application
      • 10.3.3.2.5. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Protein Assays Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Becton Dickinson and Co
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Thermo Fisher Scientific Inc.
• 14.3. Bio-Rad Laboratories Inc
• 14.4. Merck KGaA
• 14.5. Abcam PLC
• 14.6. PerkinElmer Inc.
• 14.7. QIAGEN NV
• 14.8. Lonza Group AG
• 14.9. Bio-Techne Corp
• 14.10.Illumina Inc

15. Strategic Recommendations

16. About Us & Disclaimer